Ki-1 Skin Lymphoproliferative Disorders: Management with Radiation Therapy

References

• Kadin M E. Characteristic immunologic profile of the large atypical cell in lymphomatoid papulosis. Possible implications for histogenesis and relationship to other diseases. Arch Dermatol 1986; 122: 1388–1390
   PubMed Web of Science ®Google Scholar
• Macaulay W L. Lymphomatoid papulosis. A continuing self healing eruption, clinically benign, histologically malignant. Arch Dermatol 1968; 97: 23–30
   PubMed Web of Science ®Google Scholar
• Sanchez N P, Pittelkow M R, Muller S A, et al. The clinicopathologic spectrum of lymphomatoid papulosis: Study of 31 cases. J Am Acad Dermatol 1983; 8: 81–94
   PubMed Web of Science ®Google Scholar
• Willemeze R. Lymphomatoid papulosis. Dermatol Clin 1985; 3: 735–747
   PubMed Web of Science ®Google Scholar
• Lange Wantzin G, Thomsen K, Larsen J K, et al. DNA by flow cytometry in lymphomatoid papulosis. Clin Exp Dermatol 1983; 8: 505–512
   PubMed Web of Science ®Google Scholar
• Verallo V M, Fand S B. DNA measurements in lymphomatoid papulosis: Evidence of this new entity. J Invest Dermatol 1969; 53: 51–57
   PubMed Web of Science ®Google Scholar
• Willemeze R, Meijer C J, Van Vloten L M, et al. The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol 1982; 107: 131–144
   PubMed Web of Science ®Google Scholar
• Weinman V F, Ackerman A B. Lymphomatoid papulosis. A critical review and new findings. Am J Dermatopathol 1981; 3: 129–163
   PubMed Web of Science ®Google Scholar
• Sina B, Burnett J W. Lymphomatoid papulosis. Case reports and literature review. Arch Dermatol 1983; 119: 189–197
   PubMed Web of Science ®Google Scholar
• Stein H, Mason D Y, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1982; 66: 848–858
   Google Scholar
• Chott A, Kaserer K, Augustin I, et al. Ki-1 positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 1990; 14: 439–448
   PubMed Web of Science ®Google Scholar
• Cabanillas F. Ki-1 Anaplastic large cell lymphoma. ASCO educational session. 1991; 159–160
   Google Scholar
• Beljaards R C, Meijer C LM, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large cell lymphomas of T cell origin. A clinicopathologic and immunohistochemical study in 20 patients. AmJPathol 1989; 135: 1169–1178
   Google Scholar
• Kaudewitz P, Stein H, Dallenbach F, Eckert F, et al. Primary and secondary cutaneous Ki-1 (CD30) anaplastic large cell lymphomas. Morphologic, immunologic and clinical characteristics. Am J Pathol 1989; 135: 359–367
   PubMed Web of Science ®Google Scholar
• Offit K, Ladanyi M, Gangi M D, Ebrahim S A, Filippa D, Chaganti R S. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 1990; 4: 625–630
   PubMed Web of Science ®Google Scholar
• Willemeze R, Beljaards R C. Spectrum of primary CD 30 (Ki- l)-posi-tive lymphoproliferafive disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993; 28: 973–80
   PubMed Web of Science ®Google Scholar
• Beljaards R C, Willemeze R. The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 1992; 126: 596–602
   PubMed Web of Science ®Google Scholar
• Lange Wantzin G, Thomsen K. Methotrexate in lymphomatoid papulosis. Br J Dermatol 1984; 111: 93–95
   PubMed Web of Science ®Google Scholar
• Burg G, Klepzig K, Kaudewitz P, Wolff H, et al. Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA 1986; 256: 214–215
   PubMed Web of Science ®Google Scholar
• Baumgartner G, Duschet P, Schwartz T, et al. Lymphomatoid
   Google Scholar
• Lange Wantzin G, Thomsen K:PUVA-treatment in lymphomatoid papulosis. Br J Dermatol 107:687-690,1982.
   Web of Science ®Google Scholar
• Wilson LD, Cooper DL, Goodrich AL, et al: Impact of non-CTCL dermatologic diagnosis and adjuvant therapies on cutaneous T cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys 28:82%837, 1994.
   Web of Science ®Google Scholar
• Breneman J, Breneman D: Response of total skin irradiation to mycosis fungoides associated with lymphomatoid papulosis. Int J Radiat Oncol Bid Phys 32214,1995.
   Google Scholar
• Wilson LD, Kacinski BM: In response to Drs. Breneman and Breneman. Int J Radiat Oncol Biol Phys 32:274,1995 (letter).25.Wood GS, Strickler JG, Deneau DG, et al: Lymphomatoid papulosis expresses immunophenotypes associated with Tcell lymphoma but no inflammation. J Am Acad Dermatol 15: 444–458, 1986.
   Google Scholar
• Kadin ME Common activated helper-T-cell origin for lymphomatoid paprlosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet 2864-865, 1985.
   PubMedGoogle Scholar
• Kaufmann T, Nisce LZ, Silver R Lymphomatoid paprlosis: Case report of a patient managed with radiation therapy, and review of the literature. Am J Clin Oncol 15:412416, 1992.
   PubMed Web of Science ®Google Scholar
• Nisce LZ, Safai B, Kim J H Electron beam therapy for mycosis fungoides. J Dermatd Surg Oncol4:594–599, 1978.
   Google Scholar
• Nisce LZ, D' Angio GJ: A new technique for the irradiation of large fields in patients with lymphoma Radiology 106:641–614, 1973.
   Google Scholar
• Nisce LZ, Chu FCH, Lee HS, Filipa D, Kempin S, Coleman M: Total skin electron beam therapy for cutaneous lymphomas and leukemias. Int J Radiat Oncol Biol Phys 81587-1592, 1982
   Google Scholar
• Nisce LZ, Chu FCH, Lee HS, Filipa D, Kempin S, Coleman M: Total skin electron beam therapy for cutaneous lymphomas and leukemias. Int J Radiat Oncol Biol Phys 81587-1592, 1982
   Google Scholar